(Q40737666)
Statements
Phase I trial of recombinant interleukin-2 followed by recombinant tumor necrosis factor in patients with metastatic cancer (English)
M. S. Negrier
C. N. Pourreau
P. A. Palmer
J. Y. Ranchere
A. Mercatello
P. Viens
C. Jasmin
J. L. Misset
1 February 1992